The role of the microenvironment and stromal components in WM progression and drug resistance
Stephen Ansell, MD, PhD, Mayo Clinic, Rochester, MN, discusses the role of the microenvironment in the pathophysiology of Waldenström’s macroglobulinemia (WM). He highlights key elements that regulate tumor growth and speaks about the role of stromal components in WM progression and drug resistance. This interview took place at the 12th International Workshop on Waldenström's Macroglobulinemia (IWWM-12) in Prague, Czech Republic.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.